Russian Journal of AllergyRussian Journal of AllergyРоссийский Аллергологический Журнал1810-88302686-682XPublishing House ABV Press152410.36691/RJA1524Clinical practice guidelinesКлинические рекомендацииReview ArticleAllergic rhinitisАллергический ринитhttps://orcid.org/0000-0002-7691-45849941-7013AstafievaNatalia G.АстафьеваНаталья Григорьевна
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

astang@mail.ruhttps://orcid.org/0000-0003-3987-81123570-1806BaranovAlexander A.БарановАлександр Александрович
Russian Federation

MD, Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences

д.м.н., профессор, академик РАН

baranov@pediatr-russia.ruhttps://orcid.org/0000-0001-7398-05621109-2810VishnevaElena A.ВишневаЕлена Александровна
Russian Federation

MD, Dr. Sci. (Med)

д.м.н.

vishneva.e@yandex.ruhttps://orcid.org/0000-0001-5636-50826943-2426DaihesNikolay A.ДайхесНиколай Аркадьевич
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

admin@otolar.ruhttps://orcid.org/0000-0002-3960-830X2765-9617ZhestkovAlexander V.ЖестковАлександр Викторович
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

avzhestkov2015@yandex.ruhttps://orcid.org/0000-0002-3556-969X6715-5650IlinaNatalya I.ИльинаНаталья Ивановна
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

instimmun@yandex.ruhttps://orcid.org/0000-0002-5721-16995461-1031KarneevaOlga V.КарнееваОльга Витальевна
Russian Federation

MD, Dr. Sci. (Med.), Associate Professor

д.м.н., доцент

olya.karneeva@yandex.ruhttps://orcid.org/0000-0002-4062-89571089-0533KarpovaElena P.КарповаЕлена Петровна
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

edoctor@mail.ruhttps://orcid.org/0000-0003-1078-63887493-1032KimIrina A.КимИрина Анатольевна
Russian Federation

MD, Dr. Sci. (Med.)

д.м.н.

irinakim_s@mail.ruhttps://orcid.org/0000-0002-0149-06769393-8753KryukovAndrey I.КрюковАндрей Иванович
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

lorcentr@mtu-net.ruhttps://orcid.org/0000-0003-3250-06945698-6436KurbachevaOksana M.КурбачеваОксана Михайловна
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

kurbacheva@gmail.comhttps://orcid.org/0000-0002-7806-94848937-1230MeshkovaRaisa Y.МешковаРаиса Яковлевна
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

Meshkova.raisa@yandex.ruhttps://orcid.org/0000-0002-2209-75311312-2147Namazova-BaranovaLeyla S.Намазова-БарановаЛейла Сеймуровна
Russian Federation

MD, Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences

д.м.н., профессор, академик РАН

leyla.s.namazova@gmail.comhttps://orcid.org/0000-0002-3162-25103363-6170NenashevaNatalia M.НенашеваНаталья Михайловна
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

1444031@gmail.comhttps://orcid.org/0000-0002-7571-54606289-0209NovikGennadiy A.НовикГеннадий Айзикович
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

ga_novik@mail.ruhttps://orcid.org/0000-0002-3897-83848054-9615NosulyaEvgeny V.НосуляЕвгений Владимирович
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

Nosulya@bk.ruhttps://orcid.org/0000-0002-4164-40947004658159P-9255-20177593-0838PavlovaKsenia S.ПавловаКсения Сергеевна
Russian Federation

MD, Cand. Sci. (Med.), PhD, Leading Researcher, Asthma Department

кандидат медицинских наук, ведущий научный сотрудник, отделение Бронхиальной астмы

ksenimedical@gmail.comhttps://orcid.org/0000-0001-5039-84739722-7961PampuraAlexander N.ПампураАлександр Николаевич
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

apamputa1@mail.ruhttps://orcid.org/0000-0001-7414-12939040-5720SvistushkinValery M.СвистушкинВалерий Михайлович
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

svvm3@yandex.ruhttps://orcid.org/0000-0002-3678-79395508-1689SelimzyanovaLiliya R.СелимзяноваЛилия Робертовна
Russian Federation

MD, Cand. Sci. (Med.), Associate Professor

к.м.н., доцент

lilysir@mail.ruhttps://orcid.org/0000-0003-4961-96403199-9803KhaitovMusa R.ХаитовМуса Рахимович
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

mr.khaitov@nrci.ruhttps://orcid.org/0000-0003-1829-04244004-6561KhaitovRakhim M.ХаитовРахим Мусаевич
Russian Federation

MD, Dr. Sci. (Med.), Professor, Academician of the Russian Academy of Sciences

д.м.н., профессор, академик РАН

rm.khaitov@nrcii.ruSaratov State Medical University named after V.I. RazumovskyСаратовский государственный медицинский университет имени В.И. РазумовскогоResearch Institute of Pediatrics and Children’s Health of Central Clinical Hospital of the Russian Academy of SciencesНаучно-исследовательский институт педиатрии и охраны здоровья детей ЦКБ РАНPirogov Russian National Research Medical UniversityРоссийский национальный исследовательский медицинский университет имени Н.И. ПироговаThe National Medical Research Center for Otorhinolaryngology of the Federal Medico-Biological Agency of RussiaНациональный медицинский исследовательский центр оториноларингологии Федерального медико-биологического агентстваSamara State Medical UniversityСамарский государственный медицинский университетNational Research Center ― Institute of Immunology Federal Medical-Biological Agency of RussiaГосударственный научный центр «Институт иммунологии» Федерального медико-биологического агентстваRussian Medical Academy of Continuous Professional EducationРоссийская медицинская академия непрерывного профессионального образованияThe Sverzhevskiy Otorhinolaryngology Healthcare Research InstituteНаучно-исследовательский клинический институт оториноларингологии имени Л.И. СвержевскогоMoscow State University of Medicine and Dentistry named after A.I. EvdokimovМосковский государственный медико-стоматологический университет имени А.И. ЕвдокимоваSmolensk State Medical UniversityСмоленский государственный медицинский университетSaint Petersburg State Pediatric Medical UniversityСанкт-Петербургский государственный педиатрический медицинский университетFirst Sechenov Moscow State Medical University (Sechenov University)Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)23022022060420221911001411602202217022022Copyright ©; 2022, Pharmarus Print MediaCopyright ©; 2022, Фармарус Принт Медиа2022Pharmarus Print MediaФармарус Принт Медиаhttps://rusalljournal.ru/raj/article/view/1524

Allergic rhinitis is one of the most common diseases (~10%–24% of the population experience allergic rhinitis in the Russian Federation) occurring in the population regardless of sex and age. The urgency of the problem is associated with an increase in the number of patients and the fact that allergic rhinitis is considered a risk factor for the development of asthma.

The clinical allergic rhinitis guideline aimed to optimize patient care, up-to-date information about the epidemiology, and disease etiology and pathogenesis. Herein, we present the actual data about the allergic rhinitis classification and its clinical signs and modern (clinical, laboratory, and instrumental) and differential diagnostics. Studies reported allergic rhinitis treatment, rehabilitation, and prevention in the guidelines. The authors describe in detail the existing healthcare options for patients with allergic rhinitis, diagnostic features, and care in partial groups of population (children and pregnant women). The clinical guidelines are recommended for medical doctors (independently from qualification), under- and postgraduate students, universities tutors, residents, and researchers.

Аллергический ринит ― одно из наиболее распространённых заболеваний (около 10–24% населения страдают аллергическим ринитом в Российской Федерации), встречающихся в популяции независимо от пола и возраста. Актуальность проблемы связана с увеличением количества больных и тем фактом, что аллергический ринит рассматривается как фактор риска развития бронхиальной астмы.

Представленные клинические рекомендации содержат актуальную информацию по эпидемиологии, этиологии и патогенезу заболевания; в них раскрыты особенности классификации, клинической картины и течения, современные методы клинической, лабораторной и инструментальной диагностики, а также подходы к дифференциальному диагнозу аллергического ринита. Описаны методы лечения, медицинской реабилитации и профилактики. Изложены порядок оказания медицинской помощи и особенности течения у разных групп больных (дети; беременные).

Клинические рекомендации, целью которых является оптимизация помощи больным, предназначены для практикующих врачей всех специальностей, студентов, преподавателей медицинских вузов, ординаторов, аспирантов и научных работников.

allergic rhinitisclinical practice guidelinesepidemiologypathogenesisclinical presentationdiagnosticstherapyаллергический ринитклинические рекомендацииэпидемиологияпатогенезклиническая картинадиагностикатерапияAllergology and Immunology: National guidelines. Ed. by R.M. Khaitov, N.I. Ilina. Moscow: GEOTAR-Media; 2009. 656 p. (In Russ).Аллергология и иммунология: национальное руководство / под ред. Р.М. Хаитова, Н.И. Ильиной Москва: ГЭОТАР-Медиа, 2009. 656 с.Ilyina NI, Kurbacheva OM, Pavlova KS, Polner SA. Federal clinical guidelines: Allergic rhinitis. Russian Journal of Allergy. 2017;15(2):47–54. (In Russ).Ильина Н.И., Курбачева О.М., Павлова К.С., Польнер С.А. Федеральные клинические рекомендации: Аллергический ринит // Российский аллергологический журнал. 2017. Т. 15, № 4. С. 47–54.Khaitov MR, Namazova-Baranova LS, Chuchalin AG, et al. ARIA 2016: Modern directions of medical care for patients with allergic rhinitis in the light of the requirements of precision medicine. Russian Journal of Allergy. 2017;14(3):46–54. (In Russ).Хаитов М.Р., Намазова-Баранова Л.С., Чучалин А.Г., и др. ARIA 2016: Современные направления оказания медицинской помощи больным аллергическим ринитом в свете требований прецизионной медицины // Российский аллергологический журнал. 2017. Т. 14, № 3. С. 46–54.Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2017 revision. J Allergy Clin Immunol. 2017;140(4):950–958. doi: 10/1016/j/jaci.2017.03.050Brozek J.L., Bousquet J., Baena-Cagnani C.E., et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2017 revision // J Allergy Clin Immunol. 2017. Vol. 140, N 4. Р. 950–958. doi: 10/1016/j/jaci.2017.03.050Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008;63(Suppl 86):8–160. doi: 10.1111/j.1398-9995.2007.01620.xBousquet J., Khaltaev N., Cruz A.A., et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen) // Allergy. 2008. Vol. 63, Suppl 86. Р. 8–160. doi: 10.1111/j.1398-9995.2007.01620.xKhaitov MR, Namazova-Baranova LS, Ilyina NI, et al. ARIA 2019: algorithms for providing assistance for allergic rhinitis in Russia. Russian Journal of Allergy. 2020;17(1):7–22. (In Russ). doi: 10.36691/RAJ.2020.17.1.001Хаитов М.Р., Намазова-Баранова Л.С., Ильина Н.И., и др. ARIA 2019: алгоритмы оказания помощи при аллергическом рините в России // Российский аллергологический журнал. 2020. Т. 17, № 1. С. 7–22. doi: 10.36691/RAJ.2020.17.1.001Wise SK, Lin SY, Toskala E, et al. International consensus statement on allergy and rhinology: allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108–352. doi: 10.1002/alr.22073Wise S.K., Lin S.Y., Toskala E., et al. International consensus statement on allergy and rhinology: allergic rhinitis // Int Forum Allergy Rhinol. 2018. Vol. 8, N 2. Р. 108–352. doi: 10.1002/alr.22073Global atlas of allergy. Editors: Cezmi A. Akdis, Ioana Agache. Published by the European Academy of Allergy and Clinical Immunology. 2014. 388 р.Gushchin IS. Allergic inflammation and its pharmacological control. Moscow: Farmarus Print; 1998. 250 р. (In Russ).Гущин И.С. Аллергическое воспаление и его фармакологический контроль. Москва: Фармарус Принт, 1998. 250 с.Ilyina NI, Kurbacheva OM, Pavlova KS, Ilyina EV. Screening epidemiological study (GA2LEN) for the detection of allergic diseases and respiratory diseases in Russia. Russian Journal of Allergy. 2009;(3):486–487. (In Russ).Ильина Н.И., Курбачева О.М., Павлова К.С., Ильина Е.В. Скрининговое эпидемиологическое исследование (GA2LEN) по выявлению аллергических заболеваний и заболеваний органов дыхания в России // Российский аллергологический журнал. 2009. № 3. С. 486–487.Ilyina NI, Luss LV, Kurbacheva OM, et al. The influence of climatic factors on the spectrum and structure of allergic diseases on the example of the Moscow region. Russian Journal of Allergy. 2014;(2):25–31. (In Russ).Ильина Н.И., Лусс Л. В., Курбачева О.М., и др. Влияние климатических факторов на спектр и структуру аллергических заболеваний на примере Московского региона // Российский аллергологический журнал. 2014. № 2. С. 25–31.Khaitov RM, Ilyina NI, Kurbacheva OM, Pavlova KS. Traditions, achievements and innovations in modern allergology. Physiology Pathology Immune System. 2010;14(1):3–14. (In Russ).Хаитов Р.М., Ильина Н.И., Курбачева О.М., Павлова К.С. Традиции, достижения и инновации в современной аллергологии // Физиология и патология иммунной системы. 2010. Т. 14, № 1. С. 3–14.Asher MI, Weiland SK. The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Streering Committee. Clin Exp Allergy. 1998;28(Suppl 5):52–66. dis. 90-1. doi: 10.1046/j.1365-2222.1998.028s5052.xAsher M.I., Weiland S.K. The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Streering Committee // Clin Exp Allergy. 1998. Vol. 28, Suppl. 5. P. 52–66. dis. 90-1. doi: 10.1046/j.1365-2222.1998.028s5052.xBauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758–764. doi: 10.1183/09031936.04.00013904Bauchau V., Durham S.R. Prevalence and rate of diagnosis of allergic rhinitis in Europe // Eur Respir J. 2004. Vol. 24, N 5. Р. 758–764. doi: 10.1183/09031936.04.00013904Van Cauwenberge PB, Ciprandi G, Vermeiren JS. Epidemiology of allergic rhinitis. The UCB Institute of Allergy. Brussel; 2001. 27 р.Van Cauwenberge P.B., Ciprandi G., Vermeiren J.S. Epidemiology of allergic rhinitis. The UCB Institute of Allergy. Brussel: 2001. 27 р.Pawankar R, Canonica GW, Holgate ST, et al. The World Allergy Organization White Book on Allergy; 2013.Pawankar R., Canonica G.W., Holgate S.T., et al. The World Allergy Organization White Book on Allergy, 2013.Corren J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol. 1998;101(2 Pt 2):S352–356. doi: 10.1016/s0091-6749(98)70218-0Corren J. The impact of allergic rhinitis on bronchial asthma // J Allergy Clin Immunol. 1998. Vol. 101, N 2, Pt 2. Р. S352–356. doi: 10.1016/s0091-6749(98)70218-0Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J Allergy Clin Immunol. 1992;90(4 Pt 1):579–588. doi: 10.1016/0091-6749(92)90130-tGergen P.J., Turkeltaub P.C. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II) // J Allergy Clin Immunol 1992. Vol. 90, N 4, Pt 1. Р. 579–588. doi: 10.1016/0091-6749(92)90130-tGreisner W, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc. 1998;19(4):185–188. doi: 10.2500/108854198778557836Greisner W., Settipane R.J., Settipane G.A. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students // Allergy Asthma Proc. 1998. Vol. 19, N 4. Р. 185–188. doi: 10.2500/108854198778557836Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol. 2002;109(3):419–425. doi: 10.1067/mai.2002.121701Guerra S., Sherrill D.L., Martinez F.D., Barbee R.A. Rhinitis as an independent risk factor for adult-onset asthma // J Allergy Clin Immunol. 2002. Vol. 109, N 3. Р. 419–425. doi: 10.1067/mai.2002.121701Tohidinik HR, Mallah N, Takkouche B. History of allergic rhinitis and risk of asthma; a systematic review and meta-analysis. World Allergy Organ J. 2019;12(10):100069. doi: 10.1016/j.waojou.2019.100069Tohidinik H.R., Mallah N., Takkouche B. History of allergic rhinitis and risk of asthma; a systematic review and meta-analysis // World Allergy Organ J. 2019. Vol. 12, N 10. Р. 100069. doi: 10.1016/j.waojou.2019.100069Vignola AM, Chanez P, Godard P, Bousquet J. Relationships between rhinitis and asthma. Allergy. 1998;53(9):833–839. doi: 10.1111/j.1398-9995.1998.tb03988.xVignola A.M., Chanez P., Godard P., Bousquet J. Relationships between rhinitis and asthma // Allergy. 1998. Vol. 53, N 9. Р. 833–839. doi: 10.1111/j.1398-9995.1998.tb03988.xRondón C, Campo P, Togias A, et al. Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol. 2012;129(6):1460–1467. doi: 10.1016/j.jaci.2012.02.032Rondón C., Campo P., Togias A., et al. Local allergic rhinitis: concept, pathophysiology, and management // J Allergy Clin Immunol. 2012 Jun. Vol. 129, N 6. Р. 1460–1467. doi: 10.1016/j.jaci.2012.02.032Kurbacheva OM, Pavlova KS. Allergic rhinitis and allergic conjunctivitis: one disease — two clinical forms. Russ Allergolog J. 2015;(3):22–29. (In Russ).Курбачева О.М., Павлова К.С. Аллергический ринит и аллергический конъюнктивит: одна болезнь ― две клинические формы // Российский аллергологический журнал. 2015. № 3. С. 22–29.Thomas M. Allergic rhinitis: evidence for impact on asthma. BMC Pulmonary Medicine. 2006;6(Suppl 1):S4. doi: 10.1186/1471-2466-6-S1-S4Thomas M. Allergic rhinitis: evidence for impact on asthma // BMC Pulmonary Medicine. 2006. Vol. 6, Suppl 1. Р. S4. doi: 10.1186/1471–2466-6-S1-S4Poorey VK, Soni S, Thakur P, Gupta A. Effect of nasal allergy over spirometric parameters: a prospective study. Indian J Otolaryngol Head Neck Surg. 2016;68(1):6–10. doi: 10.1007/s12070-015-0876-xPoorey V.K., Soni S., Thakur P., Gupta A. Effect of nasal allergy over spirometric parameters: a prospective study // Indian J Otolaryngol Head Neck Surg. 2016. Vol. 68, N 1. Р. 6–10. doi: 10.1007/s12070-015-0876-xTogias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol. 2000;105(6 Pt 2):S599–S604. doi: 10.1067/mai.2000.106885Togias A. Unique mechanistic features of allergic rhinitis // J Allergy Clin Immunol. 2000. Vol. 105, N 6, Pt 2. Р. S599–S604. doi: 10.1067/mai.2000.106885Kurbacheva OM, Pavlova KS, Galitskaya MA. Allergen-specific immunotherapy. Analytical review of modern international and domestic positional documents. Russ Allergolog J. 2017;14(1):24–32. (In Russ).Курбачева О.М., Павлова К.С., Галицкая М.А. Аллергенспецифическая иммунотерапия. Аналитический обзор современных международных и отечественных позиционных документов // Российский аллергологический журнал. 2017. Т. 14, № 1. С. 24–32.Calderón MA, Casale TB, Togias A, et al. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol. 2011;127(1):30–38. doi: 10.1016/j.jaci.2010.08.024Calderón M.A., Casale T.B., Togias A., et al. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond // J Allergy Clin Immunol. 2011. Vol. 127, N 1. Р. 30–38. doi: 10.1016/j.jaci.2010.08.024Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10 year follow-up on the PAT study. Allergy. 2007;62(8):943–948. doi: 10.1111/j.1398-9995.2007.01451.xJacobsen L., Niggemann B., Dreborg S., et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10 year follow-up on the PAT study // Allergy. 2007. Vol. 62, N 8. Р. 943–948. doi: 10.1111/j.1398-9995.2007.01451.xJutel M, Agache I, Bonini S, et al. Internetional Consensus On (ICON) Allergy Immunotherapy (AIT). J Allergy Clin Immunol. 2015;136(3):556–568. doi: 10.1016/j.jaci.2015.04.047Jutel M., Agache I., Bonini S., et al. Internetional Consensus On (ICON) Allergy Immunotherapy (AIT) // J Allergy Clin Immunol. 2015. Vol. 136, N 3. Р. 556–568. doi: 10.1016/j.jaci.2015.04.047Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002; 109(2):251–256. doi: 10.1067/mai.2002.121317Moller C., Dreborg S., Ferdousi H.A., et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) // J Allergy Clin Immunol. 2002. Vol. 109, N 2. Р. 251–256. doi: 10.1067/mai.2002.121317Niggemann B, Jacobsen L, Dreborg S, et al. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy. 2006;61(7):855–859. doi: 10.1111/j.1398-9995.2006.01068.xNiggemann B., Jacobsen L., Dreborg S., et al. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children // Allergy. 2006. Vol. 61, N 7. Р. 855–859. doi: 10.1111/j.1398-9995.2006.01068.xPapadopoulos NG, Arakawa H, Carlsen KH, et al. International consensus on (ICON) pediatric asthma. Allergy. 2012;67(8):976–997. doi: 10.1111/j.1398-9995.2012.02865.xPapadopoulos N.G., Arakawa H., Carlsen K.H., et al. International consensus on (ICON) pediatric asthma // Allergy. 2012. Vol. 67, N 8. Р. 976–997. doi: 10.1111/j.1398-9995.2012.02865.xZielen S, Devillier P, Heinrich J, et al. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: a retrospective, real-world database analysis. Allergy. 2018;73(1):165–177. doi: 10.1111/all.13213Zielen S., Devillier P., Heinrich J., et al. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: a retrospective, real-world database analysis // Allergy. 2018. Vol. 73, N 1. Р. 165–177. doi: 10.1111/all.13213Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62 (4):367–372. doi: 10.1111/j.1398-9995.2006.01276.xBousquet P.J., Combescure C., Neukirch F., et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines // Allergy. 2007. Vol. 62, N 4. Р. 367–372. doi: 10.1111/j.1398-9995.2006.01276.xBousquet J, Schunemann HJ, Hellings PW, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367–374.e2. doi: 10.1016/j.jaci.2016.03.025Bousquet J., Schunemann H.J., Hellings P.W., et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis // J Allergy Clin Immunol. 2016. Vol. 138, N 2. Р. 367–374.e2. doi: 10.1016/j.jaci.2016.03.025Courbis AL, Murray RB, Arnavielhe S, et al. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS. Clin Exp Allergy. 2018;48(12):1640–1653. doi: 10.1111/cea.13230Courbis A.L., Murray R.B., Arnavielhe S., et al. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS // Clin Exp Allergy. 2018. Vol. 48, N 12. Р. 1640–1653. doi: 10.1111/cea.13230Tyufin DS, Deev IA, Kobyakova OS, et al. Control of allergic rhinitis: modern assessment tools. Bulletin Siberian Med. 2019; 18(2):262–273. (In Russ). doi: 10.20538/1682-0363-2019-2-262-273Тюфилин Д.С., Деев И.А., Кобякова О.С., и др. Контроль аллергического ринита: современные инструменты оценки // Бюллетень сибирской медицины. 2019. Т. 18, № 2. С. 262–273. doi: 10.20538/1682-0363-2019-2-262-273Papadopoulos NG, Bernstein JA, Demoly P, et al. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy. 2015;70(5):474–494. doi: 10.1111/all.12573Papadopoulos N.G., Bernstein J.A., Demoly P., et al. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report // Allergy. 2015. Vol. 70, N 5. Р. 474–494. doi: 10.1111/all.12573Droste JH, Kerhof M, de Monchy JG, et al. Association of skin test reactivity, specific IgE, total IgE, and eosinophils with nasal symptoms in a community-based population study. The Dutch ECRHS Group. J Allergy Clin Immunol. 1996;97(4):922–932. doi: 10.1016/s0091-6749(96)80066-2Droste J.H., Kerhof M., de Monchy J.G., et al. Association of skin test reactivity, specific IgE, total IgE, and eosinophils with nasal symptoms in a community-based population study. The Dutch ECRHS Group // J Allergy Clin Immunol 1996. Vol. 97, N 4. Р. 922–932. doi: 10.1016/s0091-6749(96)80066-2Di Lorenzo G, Pacor ML, Amodio E, et al. Differences and similarities between allergic and nonallergic rhinitis in a large sample of adult patients with rhinitis symptoms. Int Arch Allergy Immunol. 2011;155(3):263–270. doi: 10.1159/000320050Di Lorenzo G., Pacor M.L., Amodio E., et al. Differences and similarities between allergic and nonallergic rhinitis in a large sample of adult patients with rhinitis symptoms // Int Arch Allergy Immunol. 2011. Vol. 155, N 3. Р. 263–270. doi: 10.1159/000320050Gelardi M, Passalacqua G, Fiorella ML, Quaranta N. Assessment of biofilm by nasal cytology in different forms of rhinitis and its functional correlations. Eur Ann Allergy Clin Immunol. 2013;45(1):25–29.Gelardi M., Passalacqua G., Fiorella M.L., Quaranta N. Assessment of biofilm by nasal cytology in different forms of rhinitis and its functional correlations // Eur Ann Allergy Clin Immunol. 2013. Vol. 45, N 1. Р. 25–29.Gelardi M, Peroni DG, Incorvaia C, et al. Seasonal changes in nasal cytology in mite-allergic patients. J Inflamm Res. 2014;7: 39–44. doi: 10.2147/JIR.S54581Gelardi M., Peroni D.G., Incorvaia C., et al. Seasonal changes in nasal cytology in mite-allergic patients // J Inflamm Res. 2014. Vol. 7. Р. 39–44. doi: 10.2147/JIR.S54581Park SC, Kim JH, Lee KH, et al. Association of serum eosinophilia and total immunoglobulin E concentration with the risk of allergic symptoms and allergic sensitization, respectively: a 2-year follow-up study. Int J Pediatr Otorhinolaryngol. 2016;86:167–171. doi: 10.1016/j.ijporl.2016.05.005Park S.C., Kim J.H., Lee K.H., et al. Association of serum eosinophilia and total immunoglobulin E concentration with the risk of allergic symptoms and allergic sensitization, respectively: a 2-year follow-up study // Int J Pediatr Otorhinolaryngol. 2016. Vol. 86. Р. 167–171. doi: 10.1016/j.ijporl.2016.05.005Tay TR, Bosco J, Aumann H, et al. Elevated total serum immunoglobulin E (≥1000 IU/mL): implications? Intern Med J. 2016; 46(7):846–849. doi: 10.1111/imj.13073Tay T.R., Bosco J., Aumann H., et al. Elevated total serum immunoglobulin E (≥1000 IU/mL): implications? // Intern Med J. 2016. Vol. 46, N 7. Р. 846–849. doi: 10.1111/imj.13073Satwani H, Rehman A, Ashraf S, Hassan A. Is serum total IgE levels a good predictor of allergies in children? J Pak Med Assoc. 2009;59(10):698–702.Satwani H., Rehman A., Ashraf S., Hassan A. Is serum total IgE levels a good predictor of allergies in children? // J Pak Med Assoc. 2009. Vol. 59, N 10. Р. 698–702.Tu YL, Chang SW, Tsai HJ, et al. Total serum IgE in a population-based study of Asian children in Taiwan: reference value and significance in the diagnosis of allergy. PLoS One. 2013;8(11):e80996. doi: 10.1371/journal.pone.0080996Tu Y.L., Chang S.W., Tsai H.J., et al. Total serum IgE in a population-based study of Asian children in Taiwan: reference value and significance in the diagnosis of allergy // PLoS One. 2013. Vol. 8, N 11. Р. e80996. doi: 10.1371/journal.pone.0080996Ameli F, Brocchetti F, Tosca MA, et al. Nasal endoscopy in children with suspected allergic rhinitis. Laryngoscope. 2011;121(10): 2055–2059. doi: 10.1002/lary.22156Ameli F., Brocchetti F., Tosca M.A., et al. Nasal endoscopy in children with suspected allergic rhinitis // Laryngoscope. 2011. Vol. 121, N 10. Р. 2055–2059. doi: 10.1002/lary.22156Eren E, Aktas A, Arslanoglu S, et al. Diagnosis of allergic rhinitis: inter-rater reliability and predictive value of nasal endoscopic examination: a prospective observational study. Clin Otolaryngol. 2013;38(6):481–486. doi: 10.1111/coa.12171Eren E., Aktas A., Arslanoglu S., et al. Diagnosis of allergic rhinitis: inter-rater reliability and predictive value of nasal endoscopic examination: a prospective observational study // Clin Otolaryngol. 2013. Vol. 38, N 6. Р. 481–486. doi: 10.1111/coa.12171Jareoncharsri P, Thitadilok V, Bunnag C, et al. Nasal endoscopic findings in patients with perennial allergic rhinitis. Asian Pac J Allergy Immunol. 1999;17(4):261–267.Jareoncharsri P., Thitadilok V., Bunnag C., et al. Nasal endoscopic findings in patients with perennial allergic rhinitis // Asian Pac J Allergy Immunol. 1999. Vol. 17, N 4. Р. 261–267.Brunner JP, Jawad BA, McCoul ED. Polypoid change of the middle turbinate and paranasal sinus polyposis are distinct entities. Otolaryngol Head Neck Surg. 2017;157(3):519–523. doi: 10.1177/0194599817711887Brunner J.P., Jawad B.A., McCoul E.D. Polypoid change of the middle turbinate and paranasal sinus polyposis are distinct entities // Otolaryngol Head Neck Surg. 2017. Vol. 157, N 3. Р. 519–523. doi: 10.1177/0194599817711887Tschopp JM, Sistek D, Schindler C, et al. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8329 randomized adults from the SAPALDIA Study. Swiss study on air pollution and lung diseases in adults. Allergy. 1998;53(6):608–613. doi: 10.1111/j.1398-9995.1998.tb03937.xTschopp J.M., Sistek D., Schindler C., et al. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8329 randomized adults from the SAPALDIA Study. Swiss study on air pollution and lung diseases in adults // Allergy. 1998. Vol. 53, N 6. Р. 608–613. doi: 10.1111/j.1398-9995.1998.tb03937.xNevis IF, Binkley K, Kabali C. Diagnostic accuracy of skin-prick testing for allergic rhinitis: a systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2016;12:20. doi: 10.1186/s13223-016-0126-0Nevis I.F., Binkley K., Kabali C. Diagnostic accuracy of skin-prick testing for allergic rhinitis: a systematic review and meta-analysis // Allergy Asthma Clin Immunol. 2016. Vol. 12. Р. 20. doi: 10.1186/s13223-016-0126-0Health Quality Ontario. Skin Testing for Allergic Rhinitis: A Health Technology Assessment. Ont Health Technol Assess Ser. 2016;16(10):1–45.Health Quality Ontario. Skin Testing for Allergic Rhinitis: A Health Technology Assessment // Ont Health Technol Assess Ser. 2016. Vol. 16, N 10. Р. 1–45.Nevis IF, Binkley K., Kabali C. Diagnostic accuracy of skin-prick testing for allergic rhinitis: a systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2016;12:20. doi 10.1186/s13223-016-0126-0Nevis I.F., Binkley K., Kabali C. Diagnostic accuracy of skin-prick testing for allergic rhinitis: a systematic review and meta-analysis // Allergy Asthma Clin Immunol. 2016. Vol. 12. Р. 20. doi: 10.1186/s13223-016-0126-0Liu CY, Zhang Y, Han DM, Zhang L. Evaluation of serum specific IgE for the diagnosis of allergic rhinitis with multi-allergens. Chin Med J (Engl). 2010;123(20):2836–2841.Liu C.Y., Zhang Y., Han D.M., Zhang L. Evaluation of serum specific IgE for the diagnosis of allergic rhinitis with multi-allergens // Chin Med J (Engl). 2010. Vol. 123, N 20. Р. 2836–2841.Jiang XD, Li GY, Dong Z, Zhu DD. Correlation analysis of two serum-specific immunoglobulin E test systems and skin-prick test in allergic rhinitis patients from northeast China. Am J Rhinol Allergy. 2011;25(2):116–119. doi: 10.2500/ajra.2011.25.3572Jiang X.D., Li G.Y., Dong Z., Zhu D.D. Correlation analysis of two serum-specific immunoglobulin E test systems and skin-prick test in allergic rhinitis patients from northeast China // Am J Rhinol Allergy. 2011. Vol. 25, N 2. Р. 116–119. doi: 10.2500/ajra.2011.25.3572Cox L. Overview of serological-specific IgE antibody testing in children. Curr Allergy Asthma Rep. 2011;11(6):447–453. doi: 10.1007/s11882-011-0226-3Cox L. Overview of serological-specific IgE antibody testing in children // Curr Allergy Asthma Rep. 2011. Vol. 11, N 6. Р. 447–453. doi: 10.1007/s11882-011-0226-3Hamilton RG, Oppenheimer J. Serological IgE Analyses in the Diagnostic Algorithm for Allergic Disease. J Allergy Clin Immunol Pract. 2015;3(6):833–842. doi: 10.1016/j.jaip.2015.08.016Hamilton R.G., Oppenheimer J. Serological IgE analyses in the diagnostic algorithm for allergic disease // J Allergy Clin Immunol Pract. 2015. Vol. 3, N 6. Р. 833–842. doi: 10.1016/j.jaip.2015.08.016Steering Committee Authors; Review Panel Members. A WAO-ARIA-GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@: Update 2020. World Allergy Organ J. 2020;13(2):100091. doi: 10.1016/j.waojou.2019.100091Steering Committee Authors; Review Panel Members. A WAO-ARIA-GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@: Update 2020 // World Allergy Organ J. 2020. Vol. 13, N 2. Р. 100091. doi: 10.1016/j.waojou.2019.100091Ferrer M, Sanz ML, Sastre J, et al. Molecular diagnosis in Allergology: application of the microarray technique. J Investig Allergol Clin Immunol. 2009;19(Suppl 1):19–24.Ferrer M., Sanz M.L., Sastre J., et al. Molecular diagnosis in Allergology: application of the microarray technique // J Investig Allergol Clin Immunol. 2009. Vol. 19, Suppl 1. Р. 19–24.Akdis CA, Jutel M, Akdis M. Regulatory effects of histamine and histamine receptor expression in human allergic immune responses. Chem Immunol Allergy. 2008;94:67–82. doi: 10.1159/000154858Akdis C.A., Jutel M., Akdis M. Regulatory effects of histamine and histamine receptor expression in human allergic immune responses // Chem Immunol Allergy. 2008. Vol. 94. Р. 67–82. doi: 10.1159/000154858Allocco FT, Votypka V, De Tineo M, et al. Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002;89(6):578–584. doi: 10.1016/S1081-1206(10)62105-9Allocco F.T., Votypka V., De Tineo M., et al. Effects of fexofenadine on the early response to nasal allergen challenge // Ann Allergy Asthma Immunol. 2002. Vol. 89, N 6. Р. 578–584. doi: 10.1016/S1081-1206(10)62105-9Benninger M, Farrar JR, Blaiss M, et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol. 2010;104(1):13–29. doi: 10.1016/j.anai.2009.11.020Benninger M., Farrar J.R., Blaiss M., et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class // Ann Allergy Asthma Immunol. 2010. Vol. 104, N 1. P. 13–29. doi: 10.1016/j.anai.2009.11.020Berger WE, Lumry WR, Meltzer EO, Pearlman DS. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis. Allergy Asthma Proc. 2006;27(3):214–223. doi: 10.2500/aap.2006.27.2851Berger W.E., Lumry W.R., Meltzer E.O., Pearlman D.S. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis // Allergy Asthma Proc. 2006. Vol. 27, N 3. Р. 214–223. doi: 10.2500/aap.2006.27.2851Bocsan CI, Bujor AI, Miron N, et al. In vivo anti-inflammatory effect of H1 antihistamines in allergic rhinitis: a randomized clinical trial. Balkan Med J. 2015;32(4):352–358. doi: 10.5152/balkanmedj.2015.15884Bocsan C.I., Bujor A.I., Miron N., et al. In vivo anti-inflammatory effect of H1 antihistamines in allergic rhinitis: a randomized clinical trial // Balkan Med J. 2015. Vol. 32, N 4. Р. 352–358. doi: 10.5152/balkanmedj.2015.15884Bousquet J, Bachert C, Canonica GW, et al.; ACCEPT-1 Study Group. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study. Allergy. 2009;64(10):1516–1523. doi: 10.1111/j.1398-9995.2009.02115.xBousquet J., Bachert C., Canonica G.W., et al.; ACCEPT-1 Study Group. Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study // Allergy. 2009. Vol. 64, N 10. Р. 1516–1523. doi: 10.1111/j.1398-9995.2009.02115.xCanonica GW, Tarantini F, Compalati E, Penagos M. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Allergy. 2007;62(4): 359–366. doi: 10.1111/j.1398-9995.2006.01277.xCanonica G.W., Tarantini F., Compalati E., Penagos M. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials // Allergy. 2007. Vol. 62, N 4. Р. 359–366. doi: 10.1111/j.1398-9995.2006.01277.xDe Blic J, Wahn U, Billard E, et al. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol. 2005;16(3):267–275. doi: 10.1111/j.1399-3038.2005.00216.xDe Blic J., Wahn U., Billard E., et al. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial // Pediatric Allergy Immunol. 2005. Vol. 16, N 3. Р. 267–275. doi: 10.1111/j.1399-3038.2005.00216.xDykewicz MS, Wallace DV, Baroody F, et al. Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol. 2017;119(6):489–511.e41. doi: 10.1016/j.anai.2017.08.012Dykewicz M.S., Wallace D.V., Baroody F., et al. Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update // Ann Allergy Asthma Immunol. 2017. Vol. 119, N 6. Р. 489–511.e41. doi: 10.1016/j.anai.2017.08.012Farré M, Pérez-Mañá C, Papaseit E, et al. Bilastine vs. hydroxyzine: occupation of brain histamine H1-receptors evaluated by positron emission tomography in healthy volunteers. Br J Clin Pharmacol. 2014;78(5):970–980. doi: 10.1111/bcp.12421Farré M., Pérez-Mañá C., Papaseit E., et al. Bilastine vs. hydroxyzine: occupation of brain histamine H1-receptors evaluated by positron emission tomography in healthy volunteers // Br J Clin Pharmacol. 2014. Vol. 78, N 5. Р. 970–980. doi: 10.1111/bcp.12421Gillman S, Gillard M, Strolin Benedetti M. The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines. Allergy Asthma Proc. 2009;30(4): 366–376. doi: 10.2500/aap.2009.30.3226Gillman S., Gillard M., Strolin Benedetti M. The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines // Allergy Asthma Proc. 2009. Vol. 30, N 4. Р. 366–376. doi: 10.2500/aap.2009.30.3226Leurs R, Church MK, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy. 2002;32(4):489–498. doi: 10.1046/j.0954-7894.2002.01314.xLeurs R., Church M.K., Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects // Clin Exp Allergy. 2002. Vol. 32, N 4. Р. 489–498. doi: 10.1046/j.0954-7894.2002.01314.xLukat K, Rivas P, Roger A, et al. A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study. J Asthma Allergy. 2013;(6):31–39. doi: 10.2147/JAA.S39496Lukat K., Rivas P., Roger A., et al. A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study // J Asthma Allergy. 2013. Vol. 6. Р. 31–39. doi: 10.2147/JAA.S39496Mösges R, König V, Köberlein J. The effectiveness of modern antihistamines for treatment of allergic rhinitis — an IPD meta-analysis of 140,853 patients. Allergol Int. 2013;62(2):215–222. doi: 10.2332/allergolint.12-OA-0486Mösges R., König V., Köberlein J. The effectiveness of modern antihistamines for treatment of allergic rhinitis — an IPD meta-analysis of 140,853 patients // Allergol Int. 2013. Vol. 62, N 2. Р. 215–222. doi: 10.2332/allergolint.12-OA-0486Muntean A, Bocsan I, Deleanu DM. The effect of H1-antihistamines on allergic inflammation in patients with allergic rhinitis. Human Veterinary Med. 2016, 8(4):161–165.Muntean A., Bocsan I., Deleanu D.M. The effect of H1-antihistamines on allergic inflammation in patients with allergic rhinitis // Human Veterinary Medicine. 2016. Vol. 8, N 4. Р. 161–165.Naclerio RM. The effect of antihistamines on the immediate allergic response: a comparative review. Otolaryngol Head Neck Surg. 1993,108(6):723–730. doi: 10.1177/019459989310800615Naclerio R.M. The effect of antihistamines on the immediate allergic response: a comparative review // Otolaryngol Head Neck Surg. 1993. Vol. 108, N 6. Р. 723–730. doi: 10.1177/019459989310800615Okubo K, Suzuki T, Tanaka A, Aoki H. Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: a double-blind, randomized, multicenter, placebo-controlled clinical trial. Allergol Int. 2019;68(2):207–215. doi: 10.1016/j.alit.2018.08.011Okubo K., Suzuki T., Tanaka A., Aoki H. Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: a double-blind, randomized, multicenter, placebo-controlled clinical trial // Allergol Int. 2019. Vol. 68, N 2. Р. 207–215. doi: 10.1016/j.alit.2018.08.011Valk P, Jetten A, Simons R, et al. Effects of a single oral dose of bilastine 20 mg on flying ability in healthy volunteers under conditions of simulated cabin pressure. Allergy: Eur J Allergy Clin Immunol. 2015;(70):647.Valk P., Jetten A., Simons R., et al. Effects of a single oral dose of bilastine 20 mg on flying ability in healthy volunteers under conditions of simulated cabin pressure // Allergy: Eur J Allergy Clin Immunol. 2015. Vol. 70. Р. 647.Ilina NI, Pavlova KS. Antihistamine, anti-inflammatory and anti-allergic properties of desloratadine. Consilium Medicum. 2015; 17(3):79–83. (In Russ).Ильина Н.И., Павлова К.С. Антигистминные, противовоспалительные и противоаллергические свойства дезлоратадина // Consilium Medicum. 2015. Т. 17, № 3. C. 79–83.Church MK, Maurer M, Simons FE, et al. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy. 2010;65(4):459e466. doi: 10.1111/j.1398-9995.2009.02325.xChurch M.K., Maurer M., Simons F.E., et al. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper // Allergy. 2010. Vol. 65, N 4. Р. 459–466. doi: 10.1111/j.1398-9995.2009.02325.xSimons FE. Advances in H1-antihistamines. N Engl J Med. 2004; 351(21):2203–2217. doi: 10.1056/NEJMra033121Simons F.E. Advances in H1-antihistamines // N Engl J Med. 2004. Vol. 351, N 21. Р. 2203–2217. doi: 10.1056/NEJMra033121Castillo M, Scott NW, Mustafa MZ, et al. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Cochrane Database Syst Rev. 2015;6:CD009566. doi: 10.1002/14651858.CD009566.pub2Castillo M., Scott N.W., Mustafa M.Z., et al. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis // Cochrane Database Syst Rev. 2015, N 6. Р. CD009566. doi: 10.1002/14651858.CD009566.pub2Lee TA, Pickard AS. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis. Pharmacotherapy. 2007;27(6): 852–859. doi: 10.1592/phco.27.6.852Lee T.A., Pickard A.S. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis // Pharmacotherapy. 2007. Vol. 27, N 6. Р. 852–859. doi: 10.1592/phco.27.6.852Al Sayyad JJ, Fedorowicz Z, Alhashimi D, Jamal A. Topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database Syst Rev. 2007;1:CD003163. doi: 10.1002/14651858.CD003163.pub4Al Sayyad J.J., Fedorowicz Z., Alhashimi D., Jamal A. Topical nasal steroids for intermittent and persistent allergic rhinitis in children // Cochrane Database Syst Rev. 2007, N 1. Р. CD003163. doi: 10.1002/14651858.CD003163.pub4Dibildox J. Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: results of recent clinical trials. J Allergy Clin Immunol. 2001;108(1 Suppl):S54–S58. doi: 10.1067/mai.2001.115567Dibildox J. Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: results of recent clinical trials // J Allergy Clin Immunol. 2001. Vol. 108, N 1, Suppl. Р. S54–S58. doi: 10.1067/mai.2001.115567Herman H. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost. Am J Rhinol. 2007;21(1):70–79. doi: 10.2500/ajr.2007.21.2896Herman H. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost // Am J Rhinol. 2007. Vol. 21, N 1. Р. 70–79. doi: 10.2500/ajr.2007.21.2896Penagos M, Compalati E, Tarantini F, et al. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis: meta-analysis of randomized, double-blind, placebocontrolled, clinical trials. Allergy. 2008;63(10):1280–1291. doi: 10.1111/j.1398-9995.2008.01808.xPenagos M., Compalati E., Tarantini F., et al. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis: meta-analysis of randomized, double-blind, placebocontrolled, clinical trials // Allergy. 2008. Vol. 63, N 10. Р. 1280–1291. doi: 10.1111/j.1398-9995.2008.01808.xRodrigo GJ, Neffen H. Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review. Clin Exp Allergy. 2011;41(2):160–170. doi: 10.1111/j.1365-2222.2010.03654.xRodrigo G.J., Neffen H. Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review // Clin Exp Allergy. 2011. Vol. 41, N 2. Р. 160–170. doi: 10.1111/j.1365-2222.2010.03654.xWu EL, Harris WC, Babcock CM, et al. Epistaxis risk associated with intranasal corticosteroid sprays: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2019;161(1):18–27. doi: 10.1177/0194599819832277Wu E.L., Harris W.C., Babcock C.M., et al. Epistaxis risk associated with intranasal corticosteroid sprays: a systematic review and meta-analysis // Otolaryngol Head Neck Surg. 2019. Vol. 161, N 1. Р. 18–27. doi: 10.1177/0194599819832277Yanez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2002;89(5):479–484. doi: 10.1016/S1081-1206(10)62085-6Yanez A., Rodrigo G.J. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis // Ann Allergy Asthma Immunol. 2002. Vol. 89, N 5. Р. 479–484. doi: 10.1016/S1081-1206(10)62085-6Zieglmayer P, Zieglmayer R, Bareille P, et al. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber. Curr Med Res Opin. 2008;24(6):1833–1840. doi: 10.1185/03007990802155792Zieglmayer P., Zieglmayer R., Bareille P., et al. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber // Curr Med Res Opin. 2008. Vol. 24, N 6. Р. 1833–1840. doi: 10.1185/03007990802155792DeWester J, Philpot EE, Westlund RE, et al. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc. 2003;24(5):331–337.DeWester J., Philpot E.E., Westlund R.E., et al. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis // Allergy Asthma Proc. 2003. Vol. 24, N 5. Р. 331–337.Bielory L, Chun Y, Bielory BP, Canonica GW. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis. Allergy. 2011;66(5):686–693. doi: 10.1111/j.1398-9995.2010.02543.xBielory L., Chun Y., Bielory B.P., Canonica G.W. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis // Allergy. 2011. Vol. 66, N 5. Р. 686–693. doi: 10.1111/j.1398-9995.2010.02543.xBousquet J, Meltzer EO, Couroux P, et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber. J Allergy Clin Immunol Pract. 2018;6(5):1726–1732. doi: 10.1016/j.jaip.2018.01.031Bousquet J., Meltzer E.O., Couroux P., et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber // J Allergy Clin Immunol Pract. 2018. Vol. 6, N 5. Р. 1726–1732. doi: 10.1016/j.jaip.2018.01.031Debbaneh PM, Bareiss AK, Wise SK, McCoul ED. Intranasal azelastine and fluticasone as combination therapy for allergic rhinitis: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2019;161(3):412–418. doi: 10.1177/0194599819841883Debbaneh P.M., Bareiss A.K., Wise S.K., McCoul E.D. Intranasal azelastine and fluticasone as combination therapy for allergic rhinitis: systematic review and meta-analysis // Otolaryngol Head Neck Surg. 2019. Vol. 161, N 3. Р. 412–418. doi: 10.1177/0194599819841883Hampel FC, Ratner PH, Van Bavel J, et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol. 2010;105(2):168–173. doi: 10.1016/j.anai.2010.06.008Hampel F.C., Ratner P.H., Van Bavel J., et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device // Ann Allergy Asthma Immunol. 2010. Vol. 105, N 2. Р. 168–173. doi: 10.1016/j.anai.2010.06.008Wei C. The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: a systematic review and meta-analysis. Biomed Pharmacother. 2016;(83):989–997. doi: 10.1016/j.biopha.2016.08.003Wei C. The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: a systematic review and meta-analysis // Biomed Pharmacother. 2016. Vol. 83. Р. 989–997. doi: 10.1016/j.biopha.2016.08.003Lu Y, Yin M, Cheng L. [Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis. (In Chinese)]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;49(8):659–667.Lu Y., Yin M., Cheng L. [Meta-analysis of leukotriene receptor antagonist montelukast in the treatment of allergic rhinitis. (In Chinese)] // Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014. Vol. 49, N 8. Р. 659–667.Modgill V, Badyal DK, Verghese A. Efficacy and safety of montelukast add-on therapy in allergic rhinitis. Methods Findings Exp Clin Pharmacol. 2010;32(9):669–674. doi: 10.1358/mf.2010.32.9.1533686Modgill V., Badyal D.K., Verghese A. Efficacy and safety of montelukast add-on therapy in allergic rhinitis // Methods Findings Exp Clin Pharmacol. 2010. Vol. 32, N 9. Р. 669–674. doi: 10.1358/mf.2010.32.9.1533686Ngamphaiboon J. Montelukast in general pediatric practices. J Med Assoc Thai. 2005;88(Suppl 4):S348–S351.Ngamphaiboon J. Montelukast in general pediatric practices // J Med Assoc Thai. 2005. Vol. 88, Suppl 4. Р. S348–S351.Seresirikachorn K, Chitsuthipakorn W, Kanjanawasee D, et al. Leukotriene receptor antagonist addition to h1-antihistamine is effective for treating allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2019;33(5):591–600. doi: 10.1177/1945892419844459Seresirikachorn K., Chitsuthipakorn W., Kanjanawasee D., et al. Leukotriene receptor antagonist addition to h1-antihistamine is effective for treating allergic rhinitis: a systematic review and meta-analysis // Am J Rhinol Allergy. 2019. Vol. 33, N 5. Р. 591–600. doi: 10.1177/1945892419844459Xu Y, Zhang J, Wang J. The efficacy and safety of selective h1-antihistamine versus leukotriene receptor antagonist for seasonal allergic rhinitis: a meta-analysis. PLoS One. 2014;9(11):e112815. doi: 10.1371/journal.pone.0112815Xu Y., Zhang J., Wang J. The efficacy and safety of selective H1-antihistamine versus leukotriene receptor antagonist for seasonal allergic rhinitis: a meta-analysis // PLoS One. 2014. Vol. 9, N 11. Р. e112815. doi: 10.1371/journal.pone.0112815Nayak A. A review of montelukast in the treatment of asthma and allergic rhinitis. Expert Opin Pharmacother. 2004;5(3):679–686. doi: 10.1517/14656566.5.3.679Nayak A. A review of montelukast in the treatment of asthma and allergic rhinitis // Expert Opin Pharmacother. 2004. Vol. 5, N 3. Р. 679–686. doi: 10.1517/14656566.5.3.679Polos PG. Montelukast is an effective monotherapy for mild asthma and for asthma with co-morbid allergic rhinitis. Prim Care Respir J. 2006;15(5):310–311; author reply 311-2. doi: 10.1016/j.pcrj.2006.07.003Polos P.G. Montelukast is an effective monotherapy for mild asthma and for asthma with co-morbid allergic rhinitis // Prim Care Respir J. 2006. Vol. 15, N 5. Р. 310–311; author reply 311-2. doi: 10.1016/j.pcrj.2006.07.003Watts K, Chavasse RJ. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database Syst Rev. 2012;5:CD006100. doi: 10.1002/14651858.CD006100.pub2Watts K., Chavasse R.J. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children // Cochrane Database of Syst Rev. 2012, N 5. Р. CD006100. doi: 10.1002/14651858.CD006100.pub2Khattiyawittayakun L, Seresirikachorn K, Chitsuthipakorn W, et al. Effects of decongestant addition to intranasal corticosteroid for chronic rhinitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2018;8(12):1445–1453. doi: 10.1002/alr.22193Khattiyawittayakun L., Seresirikachorn K., Chitsuthipakorn W., et al. Effects of decongestant addition to intranasal corticosteroid for chronic rhinitis: a systematic review and meta-analysis // Int Forum Allergy Rhinol. 2018. Vol. 8, N 12. Р. 1445–1453. doi: 10.1002/alr.22193Yoo JK, Seikaly H, Calhoun KH. Extended use of topical nasal decongestants. Laryngoscope. 1997;107(1):40–43. doi: 10.1097/00005537-199701000-00010Yoo J.K., Seikaly H., Calhoun K.H. Extended use of topical nasal decongestants // Laryngoscope. 1997. Vol. 107, N 1. Р. 40–43. doi: 10.1097/00005537-199701000-00010Okubo K, Okano M, Sato N, Tamaki Y. Efficacy of omalizumab for severe allergic rhinitis induced by japanese cedar pollen in patients treated with combination oral antihistamines and nasal corticosteroids. J Allergy Clin Immunol. 2019;143(2):AB424. doi: 10.1016/j.jaci.2018.12.955Okubo K., Okano M., Sato N., Tamaki Y. Efficacy of omalizumab for severe allergic rhinitis induced by japanese cedar pollen in patients treated with combination oral antihistamines and nasal corticosteroids // J Allergy Clin Immunol. 2019. Vol. 143, N 2. Р. AB424. doi: 10.1016/j.jaci.2018.12.955European Academy of Allergy & Clinical Immunology. Okubo K., et al. Poster presented at The EAACI. June 1–6, 2019, Lisbon, Poster#L1372. Available from: https://www.eaaci.org/eaaci-congresses/eaaci-2019/e-posters. Accessed: 22.02.2022.European Academy of Allergy & Clinical Immunology. Okubo K., et al. Poster presented at The EAACI. June 1–6, 2019, Lisbon, Poster#L1372. Режим доступа: https://www.eaaci.org/eaaci-congresses/eaaci-2019/e-posters. Дата обращения: 22.02.2022.Tsabouri S, Tseretopoulou X, Priftis K, et al. Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials. J Allergy Clin Immunol. 2014;2(3):332–340. doi: 10.1016/j.jaip.2014.02.001Tsabouri S., Tseretopoulou X., Priftis K., Ntzani E.E. Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials // J Allergy Clin Immunol. 2014. Vol. 2, N 3. Р. 332–340. doi: 10.1016/j.jaip.2014.02.001Yu C, Wang K, Cui X, et al. Clinical efficacy and safety of omalizumab in the treatment of allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials. Am J Rhinol Allergy. 2020;34(2):196–208. doi: 10.1177/1945892419884774Yu C., Wang K., Cui X., et al. Clinical efficacy and safety of omalizumab in the treatment of allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials // Am J Rhinol Allergy. 2020. Vol. 34, N 2. Р. 196–208. doi: 10.1177/1945892419884774Kilburn SA, Lasserson TJ, McKean MC. Pet allergen control measures for allergic asthma in children and adults. Cochrane Database Syst Rev. 2001;1:CD002989. doi: 10.1002/14651858.CD002989Kilburn S.A., Lasserson T.J., McKean M.C. Pet allergen control measures for allergic asthma in children and adults // Cochrane Database Syst Rev. 2001, N 1. Р. CD002989. doi: 10.1002/14651858.CD002989Sheikh A, Hurwitz B, Nurmatov U, van Schayck CP. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev. 2010;7:CD001563. doi: 10.1002/14651858.CD001563.pub3Sheikh A., Hurwitz B., Nurmatov U., van Schayck C.P. House dust mite avoidance measures for perennial allergic rhinitis // Cochrane Database Syst Rev. 2010, N 7. Р. CD001563. doi: 10.1002/14651858.CD001563.pub3Head K, Snidvongs K, Glew S, et al. Saline irrigation for allergic rhinitis. Cochrane Database Syst Rev. 2018;6(6):CD012597. doi: 10.1002/14651858.CD012597.pub2Head K., Snidvongs K., Glew S., et al. Saline irrigation for allergic rhinitis // Cochrane Database Syst Rev. 2018. Vol. 6, N 6. Р. CD012597. doi: 10.1002/14651858.CD012597.pub2Hermelingmeier KE, Weber RK, Hellmich M, et al. Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2012;26(5): e119–e125. doi: 10.2500/ajra.2012.26.3787Hermelingmeier K.E., Weber R.K., Hellmich M., et al. Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis // Am J Rhinol Allergy. 2012. Vol. 26, N 5. Р. e119–e125. doi: 10.2500/ajra.2012.26.3787Li CL, Lin HC, Lin CY, Hsu TF. Effectiveness of hypertonic saline nasal irrigation for alleviating allergic rhinitis in children: a systematic review and meta-analysis. J Clin Med. 2019;8(1):64. doi: 10.3390/jcm8010064Li C.L., Lin H.C., Lin C.Y., Hsu T.F. Effectiveness of hypertonic saline nasal irrigation for alleviating allergic rhinitis in children: a systematic review and meta-analysis // J Clin Med. 2019. Vol. 8, N 1. Р. 64. doi: 10.3390/jcm8010064Valerieva A, Church MK, Staevska M, et al. Micronized cellulose powder as a means to enhance intranasal symptoms-driven treatment: patients” attitudes in a real life setting. Allergy. 2016;71:13.Valerieva A., Church M.K., Staevska M., et al. Micronized cellulose powder as a means to enhance intranasal symptoms-driven treatment: patients” attitudes in a real life setting // Allergy. 2016. Vol. 71. Р. 13.Kurbacheva OM, Pavlova KS. Federal clinical guidelines. Allergen-specific immunotherapy. Russian Journal of Allergy. 2006;(4-5):55–61. (In Russ).Курбачева О.М., Павлова К.С. Федеральные клинические рекомендации. Аллергенспецифическая иммунотерапия // Российский аллергологический журнал. 2006. № 4-5. С. 55–61.Des Roches A, Paradis L, Menardo JL, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol. 1997;99(4):450–453. doi: 10.1016/s0091-6749(97)70069-1Des Roches A., Paradis L., Menardo J.L., et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children // J Allergy Clin Immunol. 1997. Vol. 99, N 4. Р. 450–453. doi: 10.1016/s0091-6749(97)70069-1Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis. Allergy. 2017;72(11):1597–1631. doi: 10.1111/all.13201Dhami S., Nurmatov U., Arasi S., et al. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis // Allergy. 2017. Vol. 72, N 11. Р. 1597–1631. doi: 10.1111/all.13201Feng B, Wu J, Chen B, et al. Efficacy and safety of sublingual immunotherapy for allergic rhinitis in pediatric patients: a meta-analysis of randomized controlled trials. Am J Rhinol Allergy. 2017; 31(1):27–35. doi: 10.2500/ajra.2017.31.4382Feng B., Wu J., Chen B., et al. Efficacy and safety of sublingual immunotherapy for allergic rhinitis in pediatric patients: A meta-analysis of randomized controlled trials // Am J Rhinol. Allergy. 2017. Vol. 31, N 1. Р. 27–35. doi: 10.2500/ajra.2017.31.4382Kim J.M., Lin S.Y., Suarez-Cuervo C. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics. 2013;131(6):1155–1167. doi: 10.1542/peds.2013-0343Kim J.M., Lin S.Y., Suarez-Cuervo C. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review // Pediatrics. 2013. Vol. 131, N 6. Р. 1155–1167. doi: 10.1542/peds.2013-0343Li Y, Yu SY, Tang R, et al. Sublingual immunotherapy tablets relieve symptoms in adults with allergic rhinitis: a meta-analysis of randomized clinical trials. Chin Med J (Engl). 2018;131(21): 2583–2588. doi: 10.4103/0366-6999.244108Li Y., Yu S.Y., Tang R., et al. Sublingual immunotherapy tablets relieve symptoms in adults with allergic rhinitis: a meta-analysis of randomized clinical trials // Chin Med J (Engl). 2018. Vol. 131, N 21. Р. 2583–2588. doi: 10.4103/0366-6999.244108Mösges R, Santiago VA, Allekotte S, et al. Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis. Clin Transl Allergy. 2019;9:29. doi: 10.1186/s13601-019-0268-5Mösges R., Santiago V.A., Allekotte S., et al. Subcutaneous immunotherapy with depigmented-polymerized allergen extracts: a systematic review and meta-analysis // Clin Transl Allergy. 2019. Vol. 9. Р. 29. doi: 10.1186/s13601-019-0268-5Purello-D’Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy. 2001;31(8):1295–1302. doi: 10.1046/j.1365-2222.2001.01027.xPurello-D’Ambrosio F., Gangemi S., Merendino R.A., et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study // Clin Exp Allergy. 2001. Vol. 31, N 8. Р. 1295–1302. doi: 10.1046/j.1365-2222.2001.01027.xRadulovic S, Calderon MA, Wilson D, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. 2010;12:CD002893. doi: 10.1002/14651858.CD002893.pub2Radulovic S., Calderon M.A., Wilson D., Durham S. Sublingual immunotherapy for allergic rhinitis // Cochrane Database Syst Rev. 2010, N 12. Р. CD002893. doi: 10.1002/14651858.CD002893.pub2Tahamiler R, Saritzali G, Canakcioglu S. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope. 2007;117(6):965–969. doi: 10.1097/MLG.0b013e31804f8141Tahamiler R., Saritzali G., Canakcioglu S. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis // Laryngoscope. 2007. Vol. 117, N 6. Р. 965–969. doi: 10.1097/MLG.0b013e31804f8141Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy. 2005;60(1):4–12. doi: 10.1111/j.1398-9995.2005.00699.xWilson D.R., Lima M.T., Durham S.R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis // Allergy. 2005. Vol. 60, N 1. Р. 4–12. doi: 10.1111/j.1398-9995.2005.00699.xKurbacheva OM, Pavlova KS, Galitskaya MA, Smirnov DS. Current ideas about the mechanisms of allergen-specific immunotherapy, potential markers of effectiveness and ways of improvement. Russian Journal of Allergy. 2017;14(4-5):5–17.Курбачева О.М., Павлова К.С., Галицкая М.А., Смирнов Д.С. Актуальные представления о механизмах аллергенспецифической иммунотерапии, потенциальных маркерах эффективности и путях совершенствования // Российский аллергологический журнал. 2017. Т. 14, № 4-5. С. 5–17.Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014;133(3):621–631. doi: 10.1016/j.jaci.2013.12.1088Akdis M., Akdis C.A. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens // J Allergy Clin Immunol. 2014. Vol. 133, N 3. Р. 621–631. doi: 10.1016/j.jaci.2013.12.1088Pfaar O, Demoly P, Gerth van Wijk R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy. 2014;69(7):854–867. doi: 10.1111/all.12383Pfaar O., Demoly P., Gerth van Wijk R., et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper // Allergy. 2014. Vol. 69, N 7. Р. 854–867. doi: 10.1111/all.12383Mishra A, Kawatra R, Gola M. Interventions for atrophic rhinitis. Cochrane Database Syst Rev. 2012;15(2):CD008280. doi: 10.1002/14651858.CD008280.pub2Mishra A., Kawatra R., Gola M. Interventions for atrophic rhinitis // Cochrane Database Syst Rev. 2012. Т. 15, N 2. Р. CD008280. doi: 10.1002/14651858.CD008280.pub2Jose J, Coatesworth AP. Inferior turbinate surgery for nasal obstruction in allergic rhinitis after failed medical treatment. Cochrane Database Syst Rev. 2010;8(12):CD005235. doi: 10.1002/14651858.CD005235.pub2Jose J., Coatesworth A.P. Inferior turbinate surgery for nasal obstruction in allergic rhinitis after failed medical treatment // Cochrane Database Syst Rev. 2010. Vol. 8, N 12. Р. CD005235. doi: 10.1002/14651858.CD005235.pub2Feng S, Han M, Fan Y, et al. Acupuncture for the treatment of allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2015;29(1):57–62. doi: 10.2500/ajra.2015.29.4116Feng S., Han M., Fan Y., et al. Acupuncture for the treatment of allergic rhinitis: a systematic review and meta-analysis // Am J Rhinol Allergy. 2015. Vol. 29, N 1. Р. 57–62. doi: 10.2500/ajra.2015.29.4116Zhang J, Zhang Y, Huang X, et al. Different acupuncture therapies for allergic rhinitis: overview of systematic reviews and network meta-analysis. Evid Based Complement Alternat Med. 2020;2020:8363027. doi: 10.1155/2020/8363027Zhang J., Zhang Y., Huang X., et al. Different acupuncture therapies for allergic rhinitis: overview of systematic reviews and network meta-analysis // Evid Based Complement Alternat Med. 2020. Vol. 2020. Р. 8363027. doi: 10.1155/2020/8363027Ant K, Pearce N, Anderson HR, et al. Global map of the prevalence of symptoms of rhino-conjunctivitis in children. The International Study of Asthma and Allergies in Childhood ISAAC Phase Three. Allergy. 2009;64(1):123–148. doi: 10.1111/j.1398-9995.2008.01884.xAnt K., Pearce N., Anderson H.R., et al. Global map of the prevalence of symptoms of rhino-conjunctivitis in children. The International Study of Asthma and Allergies in Childhood ISAAC Phase Three // Allergy. 2009. Vol. 64, N 1. Р. 123–148. doi: 10.1111/j.1398-9995.2008.01884.xMaspero JF, Rosenblut A, Finn AJ, et al. Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis. Otolaryngol Head Neck Surg. 2008;138(1):30–37. doi: 10.1016/j.otohns.2007.10.023Maspero J.F., Rosenblut A., Finn A.J., et al. Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis // Otolaryngol Head Neck Surg. 2008. Vol. 138, N 1. Р. 30–37. doi: 10.1016/j.otohns.2007.10.023Nasser M, Fedorowicz Z, Aljufairi H, McKerrow W. Antihistamines used in addition to topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database Syst Rev. 2010;7:CD006989. doi: 10.1002/14651858.CD006989.pub2Nasser M., Fedorowicz Z., Aljufairi H., McKerrow W. Antihistamines used in addition to topical nasal steroids for intermittent and persistent allergic rhinitis in children // Cochrane Database Syst Rev. 2010, N 7. Р. CD006989. doi: 10.1002/14651858.CD006989.pub2Roberts G, Xatzipsalti M, Borrego LM, et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013;68(9):1102–1116. doi: 10.1111/all.12235Roberts G., Xatzipsalti M., Borrego L.M., et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology // Allergy. 2013. Vol. 68, N 9. Р. 1102–1116. doi: 10.1111/all.12235RADAR. Allergic rhinitis in children: recommendations and algorithm for children’s allergic rhinitis. 2nd ed., reprint. and add. Moscow: Original layout; 2017. 80 р. (In Russ).РАДАР. Аллергический ринит у детей: рекомендации и алгоритм при детском аллергическом рините. 2-е изд., перераб. и доп. Москва: Оригинал-макет, 2017. 80 с.Lopatin AS. Diagnostics and treatment of rhinitis and rhinosinusitis in pregnant women. Russian Journal of Allergy. 2006;(1):12–18. (In Russ).Лопатин А.С. Диагностика и лечение ринита и риносинусита у беременных // Российский аллергологический журнал. 2006. № 1. С. 12–18.Gani F, Braida A, Lombardi C. et al. Rhinitis in pregnancy. Allerg Immunol (Paris). 2003;35(8):306–313.Gani F., Braida A., Lombardi C., et al. Rhinitis in pregnancy // Allerg Immunol (Paris). 2003. Vol. 35, N 8. Р. 306–313.Kurbacheva OM, Shvets SM. Allergic rhinitis and pregnancy: possibilities of modern therapy. Effect Pharmacother. 2013;(18): 74–80. (In Russ).Курбачева О.М., Швец С.М. Аллергический ринит и беременность: возможности современной терапии // Эффективная фармакотерапия. 2013. № 18. С. 74–80.Gilbert C, Mazzotta P, Loebstein R, Koren G. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf. 2005;28(8):707–719. doi: 10.2165/00002018-200528080-00005Gilbert C., Mazzotta P., Loebstein R., Koren G. Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review // Drug Saf. 2005. Vol. 28, N 8. Р. 707–719. doi: 10.2165/00002018-200528080-00005Yawn B, Knudtson M. Treating asthma and comorbid allergic rhinitis in pregnancy. J Am Board Fam Pract. 2007;20:289–298. doi: 10.3122/jabfm.2007.03.060144Yawn B., Knudtson M. Treating asthma and comorbid allergic rhinitis in pregnancy // J Am Board Fam Pract. 2007. Vol. 20. Р. 289–298. doi: 10.3122/jabfm.2007.03.060144Cetirizine Pregnancy and Breastfeeding Warnings. Available from: https://www.drugs.com/breastfeeding/cetirizine.html. Accessed: 22.02.2022.Cetirizine Pregnancy and Breastfeeding Warnings. Режим доступа: https://www.drugs.com/breastfeeding/cetirizine.html. Дата обращения: 22.02.2022.Kallen B, Olausson OP. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants. Eur J Clin Pharmacol. 2007;63(4):383–388. doi: 10.1007/s00228-006-0259-zKallen B., Olausson O.P. Use of anti-asthmatic drugs during pregnancy. 3. Congenital malformations in the infants // Eur J Clin Pharmacol. 2007. Vol. 63, N 4. Р. 383–388. doi: 10.1007/s00228-006-0259-z